A detailed history of Everhart Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Everhart Financial Group, Inc. holds 2,280 shares of DXCM stock, worth $158,437. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,280
Previous 2,116 7.75%
Holding current value
$158,437
Previous $293,000 11.95%
% of portfolio
0.07%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$110.31 - $140.45 $18,090 - $23,033
164 Added 7.75%
2,280 $258,000
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $241,689 - $296,451
2,116 New
2,116 $293,000
Q2 2023

Jul 13, 2023

BUY
$112.47 - $130.98 $188,724 - $219,784
1,678 New
1,678 $215,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Everhart Financial Group, Inc. Portfolio

Follow Everhart Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everhart Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Everhart Financial Group, Inc. with notifications on news.